Costa Rica — All Publications

Expedited COVID-19 R&D: Indigenous Knowledge and ABS Imperative

With the world on edge as the COVID-19 crisis progresses, the scientific community has sprung into gear in search of an effective treatment. R&D is progressing at unprecedented speeds, abridging the projected length for the completion of a vaccine from over a decade to just over a year. Amidst this rapid development, traditional knowledge plays a significant role in scientific endeavours. Through traditional knowledge, medical researchers can gain guidance and inspiration and bypass prolonged and expensive scatter-gun approaches to R&D.

Blog PostChidi OguamanamJune 5, 2020COVID-19, Health Law and Medical Ethics, Madagascar, China, WHO, Costa Rica, IP and Knowledge Governance, Indigenous, Nagoya Protocol, Biotechnology, Politics, Canada

COVID-19: In the Shadow of Ebola, the Patent War to Come and a Forgotten Africa

In the midst of the COVID-19 pandemic, the world continues to overlook the epidemic raging on in some of the poorest regions of Africa since 2013: the Ebola outbreak. The Ebola virus is a severe disease with a death rate of up to 90% in humans. The virus was first identified in 1976 with two simultaneous outbreaks; one in the Yambuku village in the Democratic Republic of the Congo (DRC) and the other in a remote area of Sudan.

Blog PostChidi OguamanamMay 22, 2020Ebola, Africa, COVID-19, DRC, Médecins Sans Frontières, WHO, United Nations, Canada, Health Law and Medical Ethics, Guinea, Liberia, China, Costa Rica, Chile, Kenya, Pharmaceutical

ALL PUblications